IP Library Granted Patent US 9,296,780
Granted Patent B2
US 9,296,780 · App. 14/367,886 · Granted Mar 29, 2016

Process for alkynylating 16-substituted-17-keto steroids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,296,780
App. No.
14/367,886
Granted
Mar 29, 2016
Kind
B2
Abstract

A process ethynylates 16-methylene-17-keto steroids to the corresponding 16-methylene-17α-ethynyl-17β-hydroxy steroids by treatment with silyl-protected lithium acetylides followed by further desilylation. The resulting products are useful intermediates in the preparation of several pharmaceutically active agents, such as e.g. Nestorone® or melengestrol acetate.

Claims (58)

1. Process for the preparation of a compound of formula (IV)

wherein

R 3 is selected from O and —OR 1 , wherein R 1 is substituted or unsubstituted C 1 -C 6 alkyl; with the proviso that when R 3 is O then there are double bonds between C 3 and R 3 and between C 4 and C 5 and single bonds between C 3 and C 4 and between C 5 and C 6 , and when R 3 is —OR 1 then there are single bonds between C 3 and R 3 and between C 4 and C 5 and double bonds between C 3 and C 4 and between C 5 and C 6 ;

R 6 is selected from H, substituted or unsubstituted C 1 -C 6 alkyl, halogen and methylene; with the proviso that when R 6 is methylene then there is a double bond between C 6 and R 6 and a single bond between C 5 and C 6 ;

R 9 is selected from H and halogen, or is absent when there is a double bond between C 9 and C 11 ;

R 11 is selected from H, OH and halogen, or is absent when there is a double bond between C 9 and C 11 ;

R 18 is selected from methyl and ethyl;

R 19 is selected from H and methyl;

is a single or double bond,

which comprises:

(a) reacting a compound of formula (II)

with a compound of formula (I)

wherein each R is independently selected from substituted or unsubstituted C 1 -C 6 alkyl, substituted or unsubstituted aryl and halogen,

to afford a compound of formula (III)

and

(b) desilylating the compound of formula (III) to afford a compound of formula (IV).

2. Process according to claim 1 , wherein the compound of formula (IV) is a compound of formula (IVa) or (IVa')

wherein R 1 ,R 6 ,R 9 ,R 18 and R 19 are as defined in claim 1 .

3. Process according to claim 1 , wherein

R 3 is selected from O or —OR 1 , wherein R 1 is a C 1 -C 3 alkyl;

R 6 is selected from H, F, methyl and methylene;

R 9 is selected from H and F;

R 11 is selected from H and OH, or there is a double bond between C 9 and C 11 and R 9 and R 11 are absent;

R 18 is selected from methyl and ethyl;

R 19 is selected from H and methyl.

4. Process according to claim 1 , wherein the compound of formula (IV) is selected from

wherein R 1 is C 1 -C 3 alkyl.

5. Process according to claim 1 , wherein each R is independently selected from C 1 -C 3 alkyl and phenyl.

6. Process according to claim 1 , wherein the compound of formula (I) is lithium trimethylsilylacetylene.

7. Process according to claim 1 , wherein desilylation step (b) is performed by treatment with potassium carbonate.

8. Process according to claim 1 , wherein the ethynylated product is further converted to a compound selected from the group formed by Nestorone®, nestorone alcohol and melengestrol acetate.

9. Process for the preparation of Nestorone alcohol according to claim 8 , which comprises the following steps:

(a) treating a compound of formula (IIa-1)

with a compound of formula (I)

to afford a compound of formula (IIIa-1)

(b) desilylating the compound of formula (IIIa-1) to afford a compound of formula (IVa-1)

(c) hydrolyzing the enol ether and hydrating the ethynyl group in the compound of formula (IVa-1) to afford a compound of formula 6

(d) reacting the compound 6 with a phenylsulfenylating agent to afford a compound of formula 7

(e) reacting compound 7 with a thiophilic reagent to afford the compound of formula 8 (Nestorone® alcohol)

10. Process according to claim 9 , which further comprises acetylating the compound of formula 8 to afford Nestorone® (9)

11. Process according to claim 1 , comprising one of the following conditions (a) to (d):

(a) wherein each R is independently selected from C 1 -C 3 alkyl and phenyl;

(b) wherein the compound of formula (I) is lithium trimethylsilylacetylene;

(c) wherein desilylation step (b) is performed by treatment with potassium carbonate;

(d) wherein the ethynylated product is further converted to a compound selected from the group formed by Nestorone®, nestorone alcohol and melengestrol acetate.

12. Process according to claim 2 , comprising one of the following conditions (a) to (f):

(a) wherein R 3 is selected from O or —OR 1 , wherein R 1 is a C 1 -C 3 alkyl;

R 6 is selected from H, F, methyl and methylene;

R 9 is selected from H and F;

R 11 is selected from H and OH, or there is a double bond between C 9 and C 11 and R 9 and R 11 are absent;

R 18 is selected from methyl and ethyl; and

R 19 is selected from H and methyl;

(b) wherein the compound of formula (IV) is selected from

wherein R 1 is C 1 -C 3 alkyl;

(c) wherein each R is independently selected from C 1 -C 3 alkyl and phenyl;

(d) wherein the compound of formula (I) is lithium trimethylsilylacetylene;

(e) wherein desilylation step (b) is performed by treatment with potassium carbonate;

(f) wherein the ethynylated product is further converted to a compound selected from the group formed by Nestorone®, nestorone alcohol and melengestrol acetate.

Assignments (5)
CHANGE OF NAME Recorded Nov 5, 2025
From: CRYSTAL PHARMA, S.A.U.
To: CURIA SPAIN, S.A.U.
Reel/Frame 073449/0630 →
TERMINATION AND RELEASE OF GRANT OF A SECURITY INTEREST - PATENTS Recorded Dec 30, 2022
From: SIXTH STREET SPECIALTY LENDING, INC. (F/K/A TPG SPECIALTY LENDING, INC.)
To: THERAPEUTICSMD, INC.
Reel/Frame 062254/0813 →
PARTIAL RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS Recorded Aug 20, 2019
From: TPG SPECIALTY LENDING, INC.
To: THERAPEUTICSMD, INC.
Reel/Frame 050110/0955 →
PATENT SECURITY AGREEMENT Recorded Apr 24, 2019
From: THERAPEUTICSMD, INC.
To: TPG SPECIALTY LENDING, INC.
Reel/Frame 048990/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2014
From: FUENTES, LUIS GERARDO GUTIÉRREZ; RODRÍGUEZ, CELSO MIGUEL SAN-DOVAL
To: CRYSTAL PHARMA, S.A.U.; POPULATION COUNCIL INC.
Reel/Frame 033376/0923 →